Lannett | LCI - Stock

Lannett reported $94.78M in Stock for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Stock Change
Ani Pharmaceuticals ANIP:US USD 105.35M 9.46M
Aurora Cannabis Inc ACB:CN CAD 122.59M 23.65M
Canopy Growth Corp WEED:CN CAD 213.94M 2.73M
Cardinal Health CAH:US USD 17.26B 1.37B
Corcept Therapeutics CORT:US USD 6.1M 10.97M
Depomed DEPO:US USD 13.7M 572K
Endo International Ordinary Shares ENDP:US USD 288.91M 1.16M
JAZZ PHA JAZZ:US USD 714.06M 14.01M
Knight Therapeutics Inc GUD:CN CAD 84.94M 8.54M
Lannett LCI:US USD 94.78M 658K
Ligand Pharmaceuticals LGND:US USD 13.29M 9.03M
Mckesson MCK:US USD 20.66B 781M
Nektar Therapeutics NKTR:US USD 19.2M 145K
Pacira Pharmaceuticals PCRX:US USD 96.06M 736K
Perrigo Ordinary Shares PRGO:US USD 1.15B 65.1M
Phibro Animal Health PAHC:US USD 288.98M 8.14M
Prestige Brands PBH:US USD 158.52M 18.02M
Supernus Pharmaceuticals SUPN:US USD 91.54M 8.38M
Teva Pharmaceutical TEVA:IT USD 3.83B 26M
Zoetis ZTS:US USD 2.35B 42M